Kitutu Freddy Eric, Namugambe Juliet Sanyu, Senkusu John, Nalubwama Juliet, Ssenkeera Ben, Kateregga John, Aineplan Noel, Kesi Diana Nakitto, Ndagije Hellen Byomire, Kasakya Eric, Mugisha Lawrence
Pharmacy Department, School of Health Sciences, Makerere University College of Health Sciences, PO Box 7072, Kampala, Uganda.
Sustainable Pharmaceutical Systems (SPS) unit, Makerere University School of Health Sciences, Kampala, Uganda.
BMC Vet Res. 2025 Apr 4;21(1):248. doi: 10.1186/s12917-025-04709-9.
Antimicrobial use in animals is one of the major drivers for the emergence and spread of resistant microorganisms. Antimicrobial resistance (AMR) can spread from animals to humans and vice versa. However, there is scanty data on antimicrobial consumption in livestock in low and middle income countries especially Uganda. Monitoring antimicrobial consumption and use (AMCU) in the veterinary sector is important to identify areas of overuse and misuse and to design targeted interventions to reduce the need for unintentional exposure. This study aimed to quantify and characterize by pharmacological class the antimicrobials intended for use in animals in different livestock production systems imported annually in Uganda.
We extracted data from the Uganda National Drug Authority (NDA) database on antimicrobials imported intended for veterinary use from 2018 to 2020. We analysed the quantities of the active pharmaceutical ingredient using the World Organization for Animal Health (WOAH) methodology and reported the consumption in kilograms and tonnes.
For our study period from 2018 to 2020; 210,419 kg, 150,032 kg and 142,069 kg of antimicrobials for animal use were imported into the country respectively with annual average importation of 167,507 kg (167.6 tons). Antibacterials accounted for 82% and antiprotozoals accounted for 18% of the total quantities over the three years. Oxytetracycline was the top most consumed antibacterial. The top five pharmacological classes were tetracyclines (22.5 tons, 44.8%), aminogylcosides + penicillin combination (15.3 tons, 29.7%), sulfonamides and trimethoprim (6.14 tons, 12.4%), macrolides (1.88 tons, 3.9%) and fluoroquinolones (1.676 tons, 3.5%). 97% (97%) of the antibacterials were from the WHO Veterinary Critically Important Antimicrobials, 57.1% were from the WHO Highly Important Antimicrobials group, 32.1% were from the Critically Important Antimicrobials group and 10.7% were from the Highest Priority group. The European Medicines Agency AMEG analysis revealed that 57.1% were from the lowest risk (D) category, 36.5% were from the intermediate risk (C) category and 6.5% were from the restricted use (B) category.
This study provides baseline data on the national-level consumption of antimicrobials used in animal health in different livestock production systems in Uganda for future reference. Annual quantification and analysis of veterinary AMCU should continue to inform monitoring distribution and use in relationship to livestock population numbers and the burden of diseases. Antimicrobial stewardship and pharmacovigilance activities in the animal health sector should focus on raising awareness to adhering to national and international guidance for appropriate and prudent use of antimicrobial agents.
动物抗菌药物的使用是耐药微生物出现和传播的主要驱动因素之一。抗菌药物耐药性(AMR)可在动物与人类之间传播,反之亦然。然而,在低收入和中等收入国家,尤其是乌干达,关于家畜抗菌药物消费的数据却很少。监测兽医部门的抗菌药物消费与使用(AMCU)对于确定过度使用和滥用的领域以及设计有针对性的干预措施以减少无意接触的必要性非常重要。本研究旨在按药理类别量化和描述乌干达每年进口的、用于不同畜牧生产系统的动物用抗菌药物情况。
我们从乌干达国家药品管理局(NDA)数据库中提取了2018年至2020年进口的用于兽医用途的抗菌药物数据。我们使用世界动物卫生组织(WOAH)的方法分析了活性药物成分的数量,并以千克和吨为单位报告了消费量。
在我们的研究期间,即2018年至2020年,该国分别进口了210,419千克、150,032千克和142,069千克动物用抗菌药物,年平均进口量为167,507千克(167.6吨)。三年中,抗菌药物占总量的82%,抗原虫药物占18%。土霉素是消费最多的抗菌药物。前五大药理类别为四环素类(22.5吨,44.8%)、氨基糖苷类+青霉素组合(15.3吨,29.7%)、磺胺类和甲氧苄啶(6.14吨,12.4%)、大环内酯类(1.88吨,3.9%)和氟喹诺酮类(1.676吨,3.5%)。97%的抗菌药物来自世界卫生组织兽医关键重要抗菌药物,57.1%来自世界卫生组织高度重要抗菌药物组,32.1%来自关键重要抗菌药物组,10.7%来自最高优先级组。欧洲药品管理局的AMEG分析显示,57.1%来自最低风险(D)类别,36.5%来自中等风险(C)类别,6.5%来自限制使用(B)类别。
本研究提供了乌干达不同畜牧生产系统中用于动物健康的抗菌药物国家级消费的基线数据,以供未来参考。应持续进行兽医AMCU的年度量化和分析,以便根据牲畜数量和疾病负担了解监测分布和使用情况。动物卫生部门的抗菌药物管理和药物警戒活动应侧重于提高认识,以遵守国家和国际关于适当和谨慎使用抗菌药物的指导。